Trial Profile
A study investigating the relationship between endothelial angiopoietin-2 expression and tumour angiogenesis and response in patients with metastatic renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics; Therapeutic Use
- 06 Aug 2015 New trial record